KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)

Clinical trial NCT02777567 · COMPLETED

Trial details

NCT number: NCT02777567
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2016-09-29
Primary completion: 2020-03-19
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.